PiperJaffray Maintains Overweight on Aravive, Raises Price Target From $15 To Street-High Of $36

PiperJaffray maintains Aravive (NASDAQ:ARAV) with a Overweight and raises the price target from $15 to $36.

Benzinga · 11/20/2019 15:35

PiperJaffray maintains Aravive (NASDAQ:ARAV) with a Overweight and raises the price target from $15 to $36.